Artwork

محتوای ارائه شده توسط Eye Tea | Ophthalmology podcast. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Eye Tea | Ophthalmology podcast یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Player FM - برنامه پادکست
با برنامه Player FM !

Ocular Oncology: Evolution and Careers - Eye Tea - Carol Karp, Prithvi Mruthyunjaya, Basil Williams

48:32
 
اشتراک گذاری
 

Manage episode 314744007 series 3289118
محتوای ارائه شده توسط Eye Tea | Ophthalmology podcast. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Eye Tea | Ophthalmology podcast یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

Join the Eye Tea Team in a conversation with Drs. Carol Karp, Prithvi Mruthyunjaya, and Basil Williams about ocular oncology, its evolution, careers in the field, and future directions.

Dr. Carol Karp holds the Richard K Forster chair in ophthalmology, as well as Dr. Ronald and Alicia Lepke endowed professorship in corneal and external diseases at Bascom Palmer Eye Institute. She's a 2013 recipient of the Women in Ophthalmology mentorship award and the 2015 recipient of the secretary to award from the American Academy of Ophthalmology. Dr. Carp is considered a leader in the area of ocular surface oncology. She has been heralded for her pioneering work on the use of interferon for the treatment of the ocular surface squamous neoplasia. She has lectured and taught both, nationally and internationally, on the management of ocular surface tumors.

Dr. Prithvi Mruthyunjaya is the director of the ocular oncology service and the vitreal retinal surgery service at the Byer's Eye Institute at Stanford University. He completed his clinical-research fellowships in Vitreoretinal surgery followed by an Ocular Oncology fellowship at the Moorfields Eye Hosptial in London, UK. As a fellow, he was recognized with the highest nationwide honors by the Heed, AOS-Knap and Ronald G Michels foundations. His academic contributions have been recognized b the American Study of Retina Specialists with the Senior honor award. He has recently been listed as one of the world's 50 most innovative retina specialists. Dr. Mruthyunhaya is actively involved in advancing diagnostic approaches to ocular tumors through imaging, genetics, and new modalities for tumor biopsies.

Dr. Basil Williams is the Mary night Ashbury endowed chair and director of the ocular oncology service of the University of Cincinnati College of medicine. He's also the director of the retinoblastoma program at Cincinnati children's hospital. And as part of the vitreoretinal service at Cincinnati Eye, he has co-authored several publications and is a prolific researcher.

  continue reading

31 قسمت

Artwork
iconاشتراک گذاری
 
Manage episode 314744007 series 3289118
محتوای ارائه شده توسط Eye Tea | Ophthalmology podcast. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Eye Tea | Ophthalmology podcast یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

Join the Eye Tea Team in a conversation with Drs. Carol Karp, Prithvi Mruthyunjaya, and Basil Williams about ocular oncology, its evolution, careers in the field, and future directions.

Dr. Carol Karp holds the Richard K Forster chair in ophthalmology, as well as Dr. Ronald and Alicia Lepke endowed professorship in corneal and external diseases at Bascom Palmer Eye Institute. She's a 2013 recipient of the Women in Ophthalmology mentorship award and the 2015 recipient of the secretary to award from the American Academy of Ophthalmology. Dr. Carp is considered a leader in the area of ocular surface oncology. She has been heralded for her pioneering work on the use of interferon for the treatment of the ocular surface squamous neoplasia. She has lectured and taught both, nationally and internationally, on the management of ocular surface tumors.

Dr. Prithvi Mruthyunjaya is the director of the ocular oncology service and the vitreal retinal surgery service at the Byer's Eye Institute at Stanford University. He completed his clinical-research fellowships in Vitreoretinal surgery followed by an Ocular Oncology fellowship at the Moorfields Eye Hosptial in London, UK. As a fellow, he was recognized with the highest nationwide honors by the Heed, AOS-Knap and Ronald G Michels foundations. His academic contributions have been recognized b the American Study of Retina Specialists with the Senior honor award. He has recently been listed as one of the world's 50 most innovative retina specialists. Dr. Mruthyunhaya is actively involved in advancing diagnostic approaches to ocular tumors through imaging, genetics, and new modalities for tumor biopsies.

Dr. Basil Williams is the Mary night Ashbury endowed chair and director of the ocular oncology service of the University of Cincinnati College of medicine. He's also the director of the retinoblastoma program at Cincinnati children's hospital. And as part of the vitreoretinal service at Cincinnati Eye, he has co-authored several publications and is a prolific researcher.

  continue reading

31 قسمت

همه قسمت ها

×
 
Loading …

به Player FM خوش آمدید!

Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.

 

راهنمای مرجع سریع